Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
- PMID: 30842092
- DOI: 10.1158/2326-6066.CIR-18-0436
Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
Abstract
Tumor microenvironment (TME) cells constitute a vital element of tumor tissue. Increasing evidence has elucidated their clinicopathologic significance in predicting outcomes and therapeutic efficacy. Nonetheless, no studies have reported a systematic analysis of cellular interactions in the TME. In this study, we comprehensively estimated the TME infiltration patterns of 1,524 gastric cancer patients and systematically correlated the TME phenotypes with genomic characteristics and clinicopathologic features of gastric cancer using two proposed computational algorithms. Three TME phenotypes were defined, and the TMEscore was constructed using principal component analysis algorithms. The high TMEscore subtype was characterized by immune activation and response to virus and IFNγ. Activation of transforming growth factor β, epithelial-mesenchymal transition, and angiogenesis pathways were observed in the low TMEscore subtype, which are considered T-cell suppressive and may be responsible for significantly worse prognosis in gastric cancer [hazard ratio (HR), 0.42; 95% confidence interval (CI), 0.33-0.54; P < 0.001]. Multivariate analysis revealed that the TMEscore was an independent prognostic biomarker, and its value in predicting immunotherapeutic outcomes was also confirmed (IMvigor210 cohort: HR, 0.63; 95% CI, 0.46-0.89; P = 0.008; GSE78220 cohort: HR, 0.25; 95% CI, 0.07-0.89; P = 0.021). Depicting a comprehensive landscape of the TME characteristics of gastric cancer may, therefore, help to interpret the responses of gastric tumors to immunotherapies and provide new strategies for the treatment of cancers.
©2019 American Association for Cancer Research.
Similar articles
-
Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.J Mol Neurosci. 2020 May;70(5):738-750. doi: 10.1007/s12031-020-01484-0. Epub 2020 Jan 31. J Mol Neurosci. 2020. PMID: 32006162
-
Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses.Front Oncol. 2021 Mar 5;11:581030. doi: 10.3389/fonc.2021.581030. eCollection 2021. Front Oncol. 2021. PMID: 33747907 Free PMC article.
-
m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer.Mol Cancer. 2020 Mar 12;19(1):53. doi: 10.1186/s12943-020-01170-0. Mol Cancer. 2020. PMID: 32164750 Free PMC article.
-
Integrated immune gene expression signature and molecular classification in gastric cancer: New insights.J Leukoc Biol. 2020 Aug;108(2):633-646. doi: 10.1002/JLB.4MR0120-221R. Epub 2020 Mar 14. J Leukoc Biol. 2020. PMID: 32170872 Review.
-
The Microenvironment of Lung Cancer and Therapeutic Implications.Adv Exp Med Biol. 2016;890:75-110. doi: 10.1007/978-3-319-24932-2_5. Adv Exp Med Biol. 2016. PMID: 26703800 Review.
Cited by
-
An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer.Front Immunol. 2022 Oct 14;13:992060. doi: 10.3389/fimmu.2022.992060. eCollection 2022. Front Immunol. 2022. PMID: 36311733 Free PMC article.
-
Gastric Cancer Tumor Microenvironment Characterization Reveals Stromal-Related Gene Signatures Associated With Macrophage Infiltration.Front Genet. 2020 Jun 30;11:663. doi: 10.3389/fgene.2020.00663. eCollection 2020. Front Genet. 2020. PMID: 32695142 Free PMC article.
-
DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in glioma.Aging (Albany NY). 2022 Sep 21;14(19):7824-7850. doi: 10.18632/aging.204291. Epub 2022 Sep 21. Aging (Albany NY). 2022. PMID: 36152044 Free PMC article.
-
COL3A1: Potential prognostic predictor for head and neck cancer based on immune-microenvironment alternative splicing.Cancer Med. 2023 Feb;12(4):4882-4894. doi: 10.1002/cam4.5170. Epub 2022 Aug 29. Cancer Med. 2023. PMID: 36039012 Free PMC article.
-
m7G regulator-mediated methylation modification patterns define immune cell infiltration and patient survival.Front Immunol. 2022 Oct 28;13:1022720. doi: 10.3389/fimmu.2022.1022720. eCollection 2022. Front Immunol. 2022. PMID: 36389726 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical